Growth rate-corrected (GR) dose-response metric signatures across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 3 of 4: Median, upper quartile, and lower quartile GR metrics per perturbagen. - Dataset (ID:20270)

Small Molecules Studied

  • Page 1 of 4
  • 1 to 25 of 95 Small Molecules
HMS LINCS ID Name Alternative Names LINCS ID Structure Image PubChem CID
10273-1 Purvalanol A LSM-3118 456214
10259-1 ICRF-193 LSM-4280 115150
10270-1 Oxamflatin LSM-4290 4611
10257-1 GSK923295 LSM-4278 68651179
10271-2 PD 98059 LSM-3394 4713
10262-1 L-779450 LSM-4283 9950176
10266-1 NSC 663284 LSM-2042 379077
10253-1 Glycyl-H-1152 LSM-4274
10251-1 Fascaplysin LSM-4272 73293
10240-1 AS-252424 LSM-4263 56965900
10268-1 Nutlin 3a LSM-6351 11433190
10267-1 NU6102 LSM-4287 4566
10255-1 GSK1838705A LSM-4276 25182616
10242-1 Carboplatin LSM-44959 5237030
10096-2 ZM-447439 LSM-1096 9914412
10026-3 PD173074 LSM-1026 1401
10107 MG-132 LSM-1107 462382
10228-2 IKK16 LSM-2309 9549298
10136-2 TPCA-1 LSM-1136 9903786
10107-2 MG-132 LSM-1107 462382
10107-5 MG-132 LSM-1107 462382
10108-2 Geldanamycin LSM-42789 644250
10250-1 Etoposide LSM-6348 36462
10275-1 (Z)-4-Hydroxytamoxifen LSM-43294 53770298
10274-1 SB-3CT LSM-4293 9883002
  • Page 1 of 4
  • 1 to 25 of 95 Small Molecules